Clinical Trials Logo

Clinical Trial Summary

There is a new form of bupivacaine, called Exparel, which can be injected into the eye socket during surgery and may provide pain relief for up to 72 hours. The purpose of the study is to compare the plain bupivacaine injection to Exparel, to see if one medication works better than the other.

Clinical Trial Description

During eye removal surgery, bupivacaine is injected, which is a numbing medicine that helps with pain, but it lasts for only 4 to 8 hours. After eye removal, some patients have pain in the eye socket that lasts for several days or up to a week. While this pain can be treated with broad based prescription pain medication, but this may cause side effects, therefore if Exparel reduces the need for additional pain medication, patients may experience better recovery. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03003741
Study type Interventional
Source University of Michigan
Status Terminated
Phase Phase 4
Start date August 31, 2015
Completion date April 16, 2018

See also
  Status Clinical Trial Phase
Completed NCT00347282 - Post Enucleation Socket Syndrome Study N/A